Payoneer Global Inc. (PAYO) Spending and interest coverage
- R&D / revenue · 12 months: Value 20.01%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 8.45%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 20.01% | Research and development expense / revenue. Period ending 2026-06-30. $171.06M ÷ $855.04M × 100 ≈ 20.01% |
| Stock-based compensation / revenue · 12 months | 8.45% | Share-based compensation / revenue. Period ending 2026-06-30. $72.29M ÷ $855.04M × 100 ≈ 8.45% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 171.06M USD | Research and Development Expense |
| Revenue | 855.04M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 72.29M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 112.22M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $171.06M | $855.04M | $72.29M | $112.22M | (m) | 20.01% | 8.45% | (m) | (m) |
| 2026-03-31 | $161.48M | $835.20M | $72.87M | $125.37M | (m) | 19.33% | 8.73% | (m) | (m) |
| 2025-12-31 | $155.42M | $813.41M | $73.10M | $124.67M | (m) | 19.11% | 8.99% | (m) | (m) |
| 2025-09-30 | $154.91M | $794.68M | $75.23M | $124.93M | (m) | 19.49% | 9.47% | (m) | (m) |
| 2025-06-30 | $149.66M | $765.35M | $74.86M | $123.74M | (m) | 19.55% | 9.78% | (m) | (m) |
| 2025-03-31 | $139.85M | $736.10M | $68.47M | $139.97M | (m) | 19.00% | 9.30% | (m) | (m) |
| 2024-12-31 | $134.63M | $710.29M | $64.79M | $149.03M | (m) | 18.95% | 9.12% | (m) | (m) |
| 2024-09-30 | $129.22M | $668.84M | $63.51M | $145.55M | (m) | 19.32% | 9.50% | (m) | (m) |
| 2024-06-30 | $121.55M | $633.68M | $61.41M | $139.89M | (m) | 19.18% | 9.69% | (m) | (m) |
| 2024-03-31 | $121.97M | $611.55M | $63.92M | $126.97M | (m) | 19.94% | 10.45% | (m) | (m) |
| 2023-12-31 | $119.20M | $590.83M | $65.77M | $103.61M | (m) | 20.17% | 11.13% | (m) | (m) |
| 2023-09-30 | $117.13M | $588.68M | $61.45M | $69.34M | (m) | 19.90% | 10.44% | (m) | (m) |
| 2023-06-30 | $119.79M | $584.93M | $59.97M | $34.74M | (m) | 20.48% | 10.25% | (m) | (m) |
| 2023-03-31 | $118.41M | $578.19M | $55.96M | $-859.00K | (m) | 20.48% | 9.68% | (m) | (m) |
| 2022-12-31 | $115.04M | $572.33M | $52.15M | $-22.21M | (m) | 20.10% | 9.11% | (m) | (m) |
| 2022-09-30 | $107.60M | $563.00M | $52.38M | $-17.84M | (m) | 19.11% | 9.30% | (m) | (m) |
| 2022-06-30 | $98.09M | $541.14M | $47.16M | $-19.25M | (m) | 18.13% | 8.71% | (m) | (m) |
| 2022-03-31 | $90.02M | $506.72M | $45.76M | $-35.40M | (m) | 17.77% | 9.03% | (m) | (m) |
| 2021-12-31 | $80.76M | $470.70M | $37.01M | $-30.21M | (m) | 17.16% | 7.86% | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $52.30M | $339.59M | $11.07M | $-17.30M | (m) | 15.40% | 3.26% | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $34.77M | $300.53M | $9.54M | $3.64M | (m) | 11.57% | 3.17% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAXIMUS, INC. (MMS) | United States | $2.759B | 7.59 |
| TIC Solutions, Inc. (TIC) | United States | $1.936B | -15.28 |
| Western Union CO (WU) | United States | $1.878B | 6.06 |
| CBIZ, Inc. (CBZ) | United States | $2.968B | 14.47 |
| TRINET GROUP, INC. (TNET) | United States | $3.008B | 13.00 |
| Shift4 Payments, Inc. (FOUR) | United States | $3.014B | 31.52 |
| Concentrix Corp (CNXC) | United States | $1.792B | -1.31 |
| ACV Auctions Inc. (ACVA) | United States | $1.775B | -19.26 |
| Nutex Health Inc. (NUTX) | United States | $1.400B | 6.53 |
| LIQUIDITY SERVICES INC (LQDT) | United States | $1.359B | 44.69 |